Cover Image
市場調查報告書

MediPoint:電生理學檢驗 - 現在/未來的主要企業

MediPoint: Electrophysiology - Current and Future Players

出版商 GlobalData 商品編碼 299749
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:電生理學檢驗 - 現在/未來的主要企業 MediPoint: Electrophysiology - Current and Future Players
出版日期: 2014年03月31日 內容資訊: 英文 136 Pages
簡介

本報告提供全球電生理學檢查裝置市場相關資料,以美國、德國、義大利、西班牙、英國、法國、中國、印度、日本、巴西為對象之切除用導管、診斷導管、檢驗系統的開發及銷售額調查分析、推動市場要素、機會及障礙以及主要趨勢、未滿足需求,再加上主要企業的競爭情形彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 現在/未來的主要企業

  • 概要、投資組合、SWOT分析等
    • Biosense Webster
    • Biotronik
    • Boston Scientific
    • CardioFocus
    • CardioInsight
    • Hansen Medical
    • Imricor
    • 日本life line
    • Magnetecs Corporation
    • Medtronic
    • MicroPort Scientific Company
    • St. Jude Medical
    • Stereotaxis
    • Stryker Sustainability Solutions
    • Topera Medical

第4章 開發中產品的評估

  • 各開發階段
  • 市場區隔分析
  • 實驗室系統

第5章 策略性交易分析

  • 主要的收購
  • 主要的夥伴關係

第6章 附錄

圖表

目錄
Product Code: GDME1023FPR

The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets.

The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Electrophysiology
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Electrophysiology market for coronary applications and peripheral applications in the lower extremity.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Current and Future Players

  • 3.1. Biosense Webster
    • 3.1.1. Overview
    • 3.1.2. Portfolio Evaluation
    • 3.1.3. Biosense Webster SWOT Analysis
  • 3.2. Biotronik
    • 3.2.1. Overview
    • 3.2.2. Portfolio Evaluation
    • 3.2.3. Biotronik SWOT Analysis
  • 3.3. Boston Scientific
    • 3.3.1. Overview
    • 3.3.2. Boston Scientific Acquires Bard EP and Rhythmia Medical
    • 3.3.3. Portfolio Evaluation
    • 3.3.4. Boston Scientific SWOT Analysis
  • 3.4. CardioFocus
    • 3.4.1. Overview
    • 3.4.2. Portfolio Evaluation
    • 3.4.3. Company SWOT Analysis
  • 3.5. CardioInsight
    • 3.5.1. Overview
    • 3.5.2. Portfolio Evaluation
    • 3.5.3. CardioInsight SWOT Analysis
  • 3.6. Hansen Medical
    • 3.6.1. Overview
    • 3.6.2. Portfolio Evaluation
    • 3.6.3. Company SWOT Analysis
  • 3.7. Imricor
    • 3.7.1. Overview
    • 3.7.2. Portfolio Evaluation
    • 3.7.3. Company SWOT Analysis
  • 3.8. Japan Lifeline
    • 3.8.1. Overview
    • 3.8.2. Portfolio Evaluation
    • 3.8.3. Company SWOT Analysis
  • 3.9. Magnetecs Corporation
    • 3.9.1. Overview
    • 3.9.2. Portfolio Evaluation
    • 3.9.3. Company SWOT Analysis
  • 3.10. Medtronic
    • 3.10.1. Overview
    • 3.10.2. Portfolio Evaluation
    • 3.10.3. Company SWOT Analysis
  • 3.11. MicroPort Scientific Company
    • 3.11.1. Overview
    • 3.11.2. Portfolio Evaluation
    • 3.11.3. MicroPort Scientific SWOT Analysis
  • 3.12. St. Jude Medical
    • 3.12.1. Overview
    • 3.12.2. Portfolio Evaluation
    • 3.12.3. Company SWOT Analysis
  • 3.13. Stereotaxis
    • 3.13.1. Overview
    • 3.13.2. Portfolio Evaluation
    • 3.13.3. Commercial Positioning
    • 3.13.4. Company SWOT Analysis
  • 3.14. Stryker Sustainability Solutions
    • 3.14.1. Overview
    • 3.14.2. Portfolio Evaluation
    • 3.14.3. Company SWOT Analysis
  • 3.15. Topera Medical
    • 3.15.1. Overview
    • 3.15.2. Portfolio Evaluation
    • 3.15.3. Company SWOT Analysis

4. Pipeline Product Assessment

  • 4.1. Pipeline Assessment by Development Stage
  • 4.2. Segment Analysis of Pipeline Products
    • 4.2.1. Ablation Catheter Pipeline Products
    • 4.2.2. Diagnostic Catheter Pipeline Products
  • 4.3. Lab Systems
    • 4.3.1. Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare)
    • 4.3.2. ClearTrace System (MRI Interventions)
    • 4.3.3. Robotic Catheter Guidance Lab System (North Carolina State University)
    • 4.3.4. Catheter Guidance Lab System (SCR)

5. Strategic Deals Analysis

  • 5.1. Key Acquisitions
    • 5.1.1. Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m
    • 5.1.2. St. Jude Medical Acquires Endosense for $161m
    • 5.1.3. Boston Scientific Acquires Rhythmia Medical for $265m
  • 5.2. Key Partnerships
    • 5.2.1. Philips and Biosense Webster Technology Integration Agreement
    • 5.2.2. Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare
    • 5.2.3. Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Report Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Secondary Research
    • 6.3.4. Forecasting Methodology
    • 6.3.5. Primary Research - Key Opinion Leader Interviews
    • 6.3.6. Expert Panel Validation
  • 6.4. Physicians Included in this Study
  • 6.5. About the Authors
    • 6.5.1. Analysts
    • 6.5.2. Global Head of Healthcare
  • 6.6. About MediPoint
  • 6.7. About GlobalData
  • 6.8. Disclaimer

List of Tables

  • Table 1: Company Profile - Biosense Webster
  • Table 2: Biosense Webster, Electrophysiology Devices Portfolio
  • Table 3: SWOT Analysis - Biosense Webster
  • Table 4: Company Profile - Biotronik
  • Table 5: Biotronik, Electrophysiology Devices Portfolio
  • Table 6: SWOT Analysis - Biotronik
  • Table 7: Company Profile - Boston Scientific
  • Table 8: Boston Scientific, Electrophysiology Devices Portfolio
  • Table 9: SWOT Analysis - Boston Scientific
  • Table 10: Company Profile - CardioFocus
  • Table 11: CardioFocus, Electrophysiology Devices Portfolio
  • Table 12: SWOT Analysis - CardioFocus
  • Table 13: Company Profile - CardioInsight
  • Table 14: CardioInsight, Electrophysiology Devices Portfolio
  • Table 15: SWOT Analysis - CardioInsight
  • Table 16: Company Profile - Hansen Medical
  • Table 17: Hansen Medical, Electrophysiology Devices Portfolio
  • Table 18: SWOT Analysis - Hansen Medical
  • Table 19: Company Profile - Imricor
  • Table 20: SWOT Analysis - Imricor
  • Table 21: Company Profile - Japan Lifeline
  • Table 22: Japan Lifeline, Electrophysiology Devices Portfolio
  • Table 23: SWOT Analysis - Japan Lifeline
  • Table 24: Company Profile - Magnetecs Corporation
  • Table 25: Magnetecs Corporation, Electrophysiology Devices Portfolio
  • Table 26: SWOT Analysis - Magnetecs Corporation
  • Table 27: Company Profile - Medtronic
  • Table 28: Medtronic, Electrophysiology Devices Portfolio, 2013
  • Table 29: SWOT Analysis - Medtronic
  • Table 30: Company Profile - MicroPort Scientific Company
  • Table 31: MicroPort Scientific, Electrophysiology Devices Portfolio
  • Table 32: SWOT Analysis - MicroPort Scientific
  • Table 33: Company Profile - St. Jude Medical
  • Table 34: St. Jude Medical, Electrophysiology Devices Portfolio
  • Table 35: SWOT Analysis - St. Jude Medical
  • Table 36: Company Profile - Stereotaxis
  • Table 37: Stereotaxis, Electrophysiology Devices Portfolio
  • Table 38: SWOT Analysis - Stereotaxis
  • Table 39: Company Profile - Stryker Sustainability Solutions
  • Table 40: Stryker Sustainability Solutions, Electrophysiology Devices Portfolio
  • Table 41: SWOT Analysis - Stryker Sustainability Solutions
  • Table 42: Company Profile - Topera Medical
  • Table 43: Topera Medical, Electrophysiology Devices Portfolio, 2013
  • Table 44: SWOT Analysis - Topera Medical
  • Table 45: Ablation Catheter Pipeline Products
  • Table 46: Diagnostic Catheter Pipeline Products
  • Table 47: Lab Systems Pipeline Products
  • Table 48: Catheter Ablation Device, Product Status
  • Table 49: Ablation Catheter Device - Transcutaneous Monitoring to Avoid Hypercapnea during Complex Catheter Ablations
  • Table 50: Apama Medical Ablation Catheter, Product Status
  • Table 51: Cooled Tip Catheter, Product Status
  • Table 52: MaPP-CS, Product Status
  • Table 53: ROF-AC, Product Status
  • Table 54: ROF-AS, Product Status
  • Table 55: Vision MR Ablation Catheter, Product Status
  • Table 56: Voyager Irrigated RFA Catheter, Product Status
  • Table 57: Navigation and Ablation Catheter, Product Status
  • Table 58: Hot Balloon Catheter, Product Status
  • Table 59: Lesion Assessment Device, Product Status
  • Table 60: Horizon MR Recording System, Product Status
  • Table 61: Integrated X-Ray and Robotic Catheter System, Product Status
  • Table 62: ClearTrace System, Product Status
  • Table 63: Robotic Catheter Guidance Lab System, Product Status
  • Table 64: Catheter Guidance Lab System, Product Status
  • Table 65: Key Acquisitions in the Electrophysiology Market
Back to Top